Myfxbook is the premier social community designed for forex traders, enabling connection with your forex trading accounts. It creates a professional hub where traders converge on Myfxbook, with their performance audited and transparency ensured, making the learning process accessible. Myfxbook aims to assist both novice and seasoned traders alike, fostering an environment conducive to skill development and shared insights.
Myfxbook is the premier social community designed for forex traders, enabling connection with your forex trading accounts. It creates a professional hub where traders converge on Myfxbook, with their performance audited and transparency ensured, making the learning process accessible. Myfxbook aims to assist both novice and seasoned traders alike, fostering an environment conducive to skill development and shared insights.
CAC 40 Edges Higher In Lackluster Trade
French stocks edged up slightly on Tuesday after suffering heavy losses in the previous session on worries that soaring inflation and aggressive policy tightening by central banks will continue to cripple growth.
FTSE 100 Slides On Growth Worries
U.K. stocks were moving lower on Tuesday amid worries about rising inflation and its impact on economic growth.
European Shares Mixed After PMI Data
European stocks traded mixed in cautious trade on Tuesday as the deepening energy crisis in the region fueled recession fears.
Sensex, Nifty End Choppy Session Higher; IT Stocks Bleed
Indian shares ended a choppy session modestly higher on Tuesday, tracking gains in European markets and the U.S. equity futures.
Medtronic Reiterates FY23 Outlook - Update
While reporting financial results for the first quarter on Tuesday, medical devices maker Medtronic plc. (MDT) reiterated its adjusted earnings and revenue growth guidance for the full-year 2023.
JD.com Q2 Net Profit Soars; Revenue Up 5.4%
e-commerce company JD.com, Inc. (JD) reported Tuesday that net income attributable to ordinary shareholders for the second quarter was RMB4.38 billion or $0.65 billion, compared to RMB0.79 billion in the year-ago
Foghorn Therapeutics Says FDA Places Clinical Hold On Phase 1 Dose Escalation Study Of FHD-286
Biotechnology company Foghorn Therapeutics Inc. (FHTX) announced Tuesday that the U.S. Food and Drug Administration (FDA) has placed a full clinical hold on the Phase 1 dose escalation study of FHD-286, an inhibitor of
Swiss Market Ends Moderately Lower
The Switzerland stock market ended notably lower on Monday after staying in the red right through the day's session, in line with the trend in most of the markets across Europe.
U.S. Stocks End Sharply Lower On Growth Worries, Rate Outlook
U.S. stocks tumbled right at the stroke of the opening bell on Monday and stayed weak right through the day's session, extending losses from the previous session.
U.S. Dollar Climbs Higher On Safe-haven Appeal
The U.S. dollar climbed higher on Monday, scoring fairly strong gains over some of its major counterparts, as investors picked up the safe-haven currency amid rising fears about a possible recession, and aggressive rate
Risk Warning:
FX trading is of high risk and may not be suitable for all investors. Leverage will create additional risks and loss. Before trading, please carefully consider your investment objectives, experience level and risk tolerance. You may lose part or all of your initial investment; do not invest money that you cannot afford. Educate yourself about the risks associated with FX trading. If you have any questions, please consult an independent financial or tax advisor. Any data and information are provided "as is" and only for information purpose, not for trading or recommendations. Past performance does not predict future results.
Business Cooperation
telegram:Please scan the QR code above to contact us.
Email:fxorone@gmail.com